Skip to content
10-Q

Quarterly Report

IGM Biosciences, Inc.

0000950170-25-100885

← back to feed
Filed
Jul 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 61.75M sh
Shares Diluted Q2 2025 · Jun 30, 2025 61.82M sh
Shares Diluted Q2 2025 · Jun 30, 2024 60.43M sh
Shares Diluted Q2 2025 · Jun 30, 2024 60.27M sh
Capex Q2 2025 · Jun 30, 2025 $32K
Capex Q2 2025 · Jun 30, 2024 $3.7M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$83.31M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$79.79M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $30.65M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $26.5M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $66.97M
Stockholders Equity Q2 2025 · Jun 30, 2025 $100.93M
Stockholders Equity Q2 2025 · Mar 31, 2025 $698K
Stockholders Equity Q2 2025 · Dec 31, 2024 $48.17M
Stockholders Equity Q2 2025 · Jun 30, 2024 $122.36M
Stockholders Equity Q2 2025 · Mar 31, 2024 $161.25M
Stockholders Equity Q2 2025 · Dec 31, 2023 $203.23M
Current Liabilities Q2 2025 · Jun 30, 2025 $6.06M
Current Liabilities Q2 2025 · Dec 31, 2024 $37.64M
Total Liabilities Q2 2025 · Jun 30, 2025 $6.06M
Total Liabilities Q2 2025 · Dec 31, 2024 $217.54M
Current Assets Q2 2025 · Jun 30, 2025 $106.99M
Current Assets Q2 2025 · Dec 31, 2024 $193.62M
Total Assets Q2 2025 · Jun 30, 2025 $106.99M
Total Assets Q2 2025 · Dec 31, 2024 $265.71M
Eps Diluted Q2 2025 · Jun 30, 2025 $1.58
Eps Diluted Q2 2025 · Jun 30, 2025 $0.72
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.79
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.62
Eps Basic Q2 2025 · Jun 30, 2025 $1.59
Eps Basic Q2 2025 · Jun 30, 2025 $0.73
Eps Basic Q2 2025 · Jun 30, 2024 −$0.79
Eps Basic Q2 2025 · Jun 30, 2024 −$1.62
Sga Expense Q2 2025 · Jun 30, 2025 $9.58M
Sga Expense Q2 2025 · Jun 30, 2025 $20.63M
Sga Expense Q2 2025 · Jun 30, 2024 $10.65M
Sga Expense Q2 2025 · Jun 30, 2024 $21.19M
Rd Expense Q2 2025 · Jun 30, 2025 $5.86M
Rd Expense Q2 2025 · Jun 30, 2025 $28.2M
Rd Expense Q2 2025 · Jun 30, 2024 $41.96M
Rd Expense Q2 2025 · Jun 30, 2024 $85.78M
Net Income Q2 2025 · Jun 30, 2025 $97.58M
Net Income Q2 2025 · Jun 30, 2025 $44.69M
Net Income Q2 2025 · Mar 31, 2025 −$52.89M
Net Income Q2 2025 · Jun 30, 2024 −$47.9M
Net Income Q2 2025 · Jun 30, 2024 −$97.72M
Net Income Q2 2025 · Mar 31, 2024 −$49.82M
Operating Income Q2 2025 · Jun 30, 2025 $96.26M
Operating Income Q2 2025 · Jun 30, 2025 $41.49M
Operating Income Q2 2025 · Jun 30, 2024 −$51.36M
Operating Income Q2 2025 · Jun 30, 2024 −$105.21M